NCT05154487 2026-03-03A Study of Alpelisib and Fulvestrant to Treat Endometrial CancerGOG FoundationPhase 2 Active not recruiting51 enrolled
NCT06105632 2026-02-13A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of TreatmentPfizerPhase 2 Active not recruiting333 enrolled